EUVIMEDEUVIMED entdecken
Crossref

A Non-Metallic DNA Intercalator from Pyronine-Aloperine Conjugation Reverses Cisplatin Resistance in Ovarian Cancer

Ling-Li Wang, Xintong Zhu, Linyu Li, Jing-Yi Jin iD, Yuewei Zhang, Songling Zhang

Journal of Medicinal Chemistry · 11.09.2026

DOI: 10.1021/acs.jmedchem.6c00799 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 11.09.2026. Verfasst von Ling-Li Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, First Hospital of Jilin University, Jilin University, Changchun130021, China. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Drug Resistance, Neoplasm, Intercalating Agents, Cisplatin. Die Arbeit nennt 40 Literaturangaben. Gefördert von: China Postdoctoral Science Foundation, National Natural Science Foundation of China (NSFC), Jilin Provincial Science and Technology Development Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cisplatin (DDP) resistance remains a key factor contributing to the high mortality rate among ovarian cancer patients. The Pt(II)−DNA covalent adduct is prone to removal through changes in gene expression in tumor cells, resulting in DDP resistance. To address this challenge, developing a non-metallic DNA intercalator is crucial. In this study, we incorporate the alkaloid aloperine (Alo) into a traditional RNA-binding agent, pyronine (PY), yielding a pyronine−aloperine conjugate (PY−Alo) as a nucleus-targeted DNA intercalator. In the PY−Alo structure, the PY scaffold intercalates between DNA base pairs, and the bridged nitrogen atom in the Alo moiety forms an additional hydrogen bond with DNA bases. PY−Alo can induce synergistic apoptosis and autophagy in A2780/DDP cells. In vivo evaluations demonstrate that PY−Alo significantly inhibits the progression of cisplatin-resistant ovarian cancer, with favorable biosafety. This study also illustrates a feasible strategy for converting a natural alkaloid into a DNA intercalator as a chemotherapeutic agent.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ovarian NeoplasmsDrug Resistance, NeoplasmIntercalating AgentsCisplatinAntineoplastic AgentsPyroninePiperidinesPhenanthrolinesFemaleHumansAnimalsCell Line, TumorApoptosisDNAMice

Stichwörter der Autor:innen

DNA intercalatoraloperinechemotherapycisplatin-resistant ovarian cancerpyronine

Substanzen

Intercalating AgentsCisplatinAntineoplastic AgentsPyronineDNAPiperidinesPhenanthrolines

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, First Hospital of Jilin University, Jilin University, Changchun130021, China.
  • Joint Laboratory of Opto-Functional Theranostics in Medicine and Chemistry, First Hospital of Jilin University, 133002, Jilin University, Changchun130021, China.
  • Research Centre of Chemical Biology, College of Science, Yanbian University, Yanji133002, China.
  • State Key Laboratory of Supramolecular Structure and Materials, Center for Supramolecular Chemical Biology, College of Chemistry, Jilin University, Changchun130012, China.
  • School of Pharmaceutical Sciences, Jilin University, 1266 Fujin Road, Changchun130012, China.

ORCID-Profile: Jing-Yi Jin

Förderung

  • China Postdoctoral Science Foundation
  • National Natural Science Foundation of China (NSFC)
  • Jilin Provincial Science and Technology Development Program
  • "Medicine + X″ Interdisciplinary Innovation Team of Norman Bethune Health Science Center of Jilin University
  • ?Medicine + X? Interdisciplinary Innovation Team of Norman Bethune Health Science Center of Jilin University

Zitieren

APA

Wang, L. L., Zhu, X., Li, L., Jin, J. Y., Zhang, Y., & Zhang, S. (2026). A Non-Metallic DNA Intercalator from Pyronine-Aloperine Conjugation Reverses Cisplatin Resistance in Ovarian Cancer. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.6c00799

Vancouver

Wang LL, Zhu X, Li L, Jin JY, Zhang Y, Zhang S. A Non-Metallic DNA Intercalator from Pyronine-Aloperine Conjugation Reverses Cisplatin Resistance in Ovarian Cancer. Journal of Medicinal Chemistry. 2026. doi:10.1021/acs.jmedchem.6c00799

BibTeX
@article{Wang2026,
  author = {Wang, Ling-Li and Zhu, Xintong and Li, Linyu and Jin, Jing-Yi and Zhang, Yuewei and Zhang, Songling},
  title = {A Non-Metallic DNA Intercalator from Pyronine-Aloperine Conjugation Reverses Cisplatin Resistance in Ovarian Cancer},
  journal = {Journal of Medicinal Chemistry},
  year = {2026},
  doi = {10.1021/acs.jmedchem.6c00799}
}
Kostenlos starten →